MyFinsight
Home
Blog
About
Cash and cash
equivalents
$36,473K
(-39.14%↓ Y/Y)
Prepaid expenses and
other current assets
$1,267K
(15.08%↑ Y/Y)
Total current assets
$37,740K
(-38.16%↓ Y/Y)
Operating leases
right-of-use assets, net
$1,373K
(0.00%↑ Y/Y)
Property and equipment,
net of accumulated...
$700K
(158.30%↑ Y/Y)
Restricted cash long-term
$339K
(3.04%↑ Y/Y)
Finance leases
right-of-use assets, net
$5K
(-66.67%↓ Y/Y)
Total assets
$40,157K
(-36.28%↓ Y/Y)
Total liabilities and
stockholders equity
$40,157K
(-36.28%↓ Y/Y)
Total stockholders
equity
$30,302K
(59.38%↑ Y/Y)
Total liabilities
$9,855K
(-77.60%↓ Y/Y)
Accumulated deficit
-$387,334K
(2.84%↑ Y/Y)
Accumulated other
comprehensive loss
-$60K
Additional paid-in capital
$417,665K
(0.01%↑ Y/Y)
Total current
liabilities
$9,260K
(11.38%↑ Y/Y)
Long-term operating lease
obligations
$595K
(-13.14%↓ Y/Y)
Common stock, 0.001 par
value 1,000,000,000...
$31K
(0.00%↑ Y/Y)
Accounts payable and
accrued expenses
$8,514K
(10.37%↑ Y/Y)
Operating leases current
liability
$741K
(25.81%↑ Y/Y)
Finance leases current
liability
$5K
(-54.55%↓ Y/Y)
Back
Back
Balance Sheet
Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals, Inc. (ATNM)
source: myfinsight.com